Mechanism of action
Nitrous oxide produces analgesia and anesthesia through multiple mechanisms acting on the central nervous system.
The primary mechanism involves non-competitive antagonism of NMDA (N-methyl-D-aspartate) receptors, which reduces excitatory neurotransmission in pain pathways and consciousness centers. This accounts for much of its analgesic and amnestic properties.
Nitrous oxide also activates opioid receptors, particularly mu, delta, and kappa subtypes, contributing significantly to its analgesic effects. The analgesic potency can be partially reversed by naloxone, supporting opioid involvement.
Additional mechanisms include:
- Activation of descending noradrenergic pain pathways
- Facilitation of GABAergic inhibitory transmission
- Release of endogenous opioid peptides and endocannabinoids
- Inhibition of nicotinic acetylcholine receptors
Nitrous oxide has a low blood-gas partition coefficient (0.47), meaning it rapidly equilibrates between alveolar gas and blood, leading to fast onset and offset of effects. It is a weak anesthetic agent with a minimum alveolar concentration (MAC) of approximately 105%, meaning it cannot produce surgical anesthesia alone at atmospheric pressure.
- Nitrous oxide irreversibly oxidizes vitamin B12, inactivating methionine synthase and causing megaloblastic anemia and subacute combined degeneration with chronic exposure
- MAC of nitrous oxide is 105%, so it cannot produce surgical anesthesia alone at atmospheric pressure; used as adjunct
- Low blood-gas partition coefficient (0.47) results in rapid onset and offset of effects
- Contraindicated in pneumothorax, bowel obstruction, and recent intraocular gas injection due to expansion of gas-filled spaces (35× more soluble than nitrogen)
- Diffusion hypoxia can occur during emergence; prevent by administering supplemental oxygen for 5-10 minutes after discontinuation
- Recreational abuse presents with subacute combined degeneration clinically identical to B12 deficiency but with normal/elevated serum B12 levels
- Second gas effect: rapid uptake of nitrous oxide concentrates remaining alveolar gases, accelerating uptake of volatile anesthetics
- Mechanism involves NMDA receptor antagonism and opioid receptor agonism, producing analgesia and amnesia
Indications
Nitrous oxide is used in multiple clinical settings for its analgesic and anesthetic properties.
Anesthesia applications
- Adjunct to general anesthesia: Combined with volatile anesthetics or intravenous agents to reduce the required dose of more potent agents (MAC reduction)
- Balanced anesthesia technique: Part of multimodal anesthetic regimens for surgical procedures
Analgesia applications
- Labor analgesia: Self-administered 50% nitrous oxide mixture for pain relief during childbirth
- Dental procedures: Conscious sedation and anxiolysis during dental work
- Minor surgical procedures: Wound repair, fracture reduction, dressing changes
- Emergency department analgesia: Rapid-onset pain control for trauma and acute pain
Other uses
- Pediatric procedures: Anxiolysis and procedural sedation in children
- Endoscopy: Adjunct sedation for gastrointestinal procedures
Nitrous oxide is particularly valuable when rapid onset, easy titration, and quick recovery are desired. Its use has declined in some settings due to environmental and occupational exposure concerns.
Pharmacokinetics
Nitrous oxide exhibits unique pharmacokinetic properties that distinguish it from other inhalational agents.
Absorption and distribution
Rapid uptake: The low blood-gas partition coefficient (0.47) allows quick equilibration between inspired concentration and alveolar partial pressure. Onset of analgesia occurs within 2-5 minutes.
Second gas effect: When administered with other volatile anesthetics, the rapid uptake of large volumes of nitrous oxide concentrates the remaining alveolar gases, accelerating uptake of companion anesthetics.
Diffusion into closed spaces: Nitrous oxide diffuses into air-filled cavities faster than nitrogen diffuses out (35 times more soluble than nitrogen in blood). This causes expansion of pneumothorax, bowel gas, middle ear spaces, and pneumocephalus.
Metabolism
Nitrous oxide undergoes minimal biotransformation in humans (less than 0.004%). It is primarily eliminated unchanged through the lungs.
A critical metabolic interaction occurs with vitamin B12 (cobalamin). Nitrous oxide irreversibly oxidizes the cobalt atom in vitamin B12 from the Co+ to Co2+ or Co3+ state, inactivating methionine synthase, an enzyme essential for DNA synthesis and myelin formation.
Elimination
Pulmonary elimination: Nitrous oxide is eliminated almost entirely through exhalation. Recovery is rapid, with most elimination occurring within 5-10 minutes after discontinuation.
Diffusion hypoxia: Upon discontinuation, rapid diffusion of nitrous oxide from blood into alveoli can dilute alveolar oxygen, potentially causing hypoxemia. This is prevented by administering supplemental oxygen during emergence.
Adverse effects
Nitrous oxide can produce various adverse effects, ranging from minor to severe with chronic exposure.
Hematologic effects
Megaloblastic anemia: Prolonged exposure (typically >6 hours or repeated exposures) inactivates vitamin B12, inhibiting methionine synthase and disrupting DNA synthesis. This leads to impaired erythropoiesis and megaloblastic anemia.
Leukopenia and thrombocytopenia: Can occur with extended exposure through the same mechanism.
Neurologic effects
Subacute combined degeneration of the spinal cord: Chronic exposure causes demyelination of dorsal and lateral columns, presenting with paresthesias, ataxia, loss of proprioception and vibration sense, and upper motor neuron signs. This mimics vitamin B12 deficiency neuropathy.
Peripheral neuropathy: Sensory and motor deficits can develop with prolonged or repeated exposure.
Postoperative nausea and vomiting (PONV): Nitrous oxide increases PONV risk, likely through effects on the chemoreceptor trigger zone and vestibular system.
Cardiovascular effects
- Mild sympathetic stimulation with slight increases in heart rate and blood pressure
- Generally maintains cardiovascular stability
- May increase pulmonary vascular resistance
Expansion of closed gas spaces
Diffusion into air-filled cavities can cause:
- Expansion of pneumothorax
- Bowel distension
- Middle ear pressure changes and tympanic membrane rupture
- Expansion of pneumocephalus
- Expansion of intraocular gas bubbles (after retinal surgery)
Other effects
- Diffusion hypoxia: Occurs during emergence if supplemental oxygen is not provided
- Immunosuppression: Inhibition of methionine synthase affects immune cell function
- Teratogenicity concerns: Animal studies suggest potential risks; avoid in early pregnancy when possible
- Reproductive toxicity: Chronic occupational exposure linked to reduced fertility and spontaneous abortion in healthcare workers
- Environmental impact: Potent greenhouse gas contributing to climate change
Contraindications and warnings
Several absolute and relative contraindications exist for nitrous oxide use.
Absolute contraindications
- Pneumothorax or pneumomediastinum: Nitrous oxide will expand air collections, worsening the condition
- Bowel obstruction or ileus: Risk of significant bowel distension
- Middle ear surgery or acute middle ear pathology: Pressure changes can disrupt tympanic membrane or surgical repair
- Recent intraocular gas injection: Used in retinal surgery; nitrous oxide causes dangerous expansion
- Severe vitamin B12 deficiency: Will worsen existing neurologic and hematologic complications
- Known or suspected pneumocephalus: Expansion can increase intracranial pressure
Relative contraindications and warnings
Vitamin B12 or folate deficiency: Even subclinical deficiency increases risk of neurologic complications. Consider checking B12 levels in high-risk patients.
Pre-existing neurologic disorders: Patients with multiple sclerosis, peripheral neuropathy, or other demyelinating conditions may be more susceptible to nitrous oxide neurotoxicity.
MTHFR gene mutations: Methylenetetrahydrofolate reductase deficiency may increase susceptibility to nitrous oxide toxicity.
Pregnancy: Generally avoided in first trimester due to theoretical teratogenic risk from methionine synthase inhibition. Used cautiously in labor analgesia.
Pulmonary hypertension: May increase pulmonary vascular resistance.
Prolonged procedures: Limit exposure duration when possible; consider avoiding for procedures exceeding 4-6 hours.
Recreational abuse: Chronic recreational use causes severe neurologic injury and myelopathy.
Special populations
Healthcare workers with chronic occupational exposure should be monitored for signs of B12 deficiency. Adequate scavenging systems are essential to minimize exposure.
Drug interactions
Nitrous oxide interacts with various medications and substances.
Anesthetic agents
Volatile anesthetics: Nitrous oxide reduces the MAC of halogenated agents (sevoflurane, desflurane, isoflurane) by 25-50%, allowing lower concentrations of potent agents. The second gas effect accelerates uptake of companion volatile agents.
Intravenous anesthetics: Additive CNS depressant effects with propofol, ketamine, benzodiazepines, and opioids. Dose reduction of these agents may be appropriate.
Neuromuscular blocking agents: No significant pharmacokinetic interaction, but nitrous oxide may provide additional muscle relaxation through central mechanisms.
Metabolic interactions
Methotrexate: Both inhibit folate metabolism through different mechanisms. Combined use may increase risk of hematologic toxicity, though this interaction is more theoretical than clinically proven.
Vitamin B12 and folate supplementation: Prophylactic supplementation does not prevent acute methionine synthase inactivation but may be beneficial for patients receiving repeated exposures.
CNS depressants
Opioids: Synergistic analgesic effects through complementary mechanisms (nitrous oxide activates endogenous opioid pathways).
Benzodiazepines and sedatives: Additive sedative and anxiolytic effects.
Alcohol: Enhanced CNS depression; both act on NMDA receptors.
Other interactions
Sympathomimetics: Nitrous oxide causes mild sympathetic stimulation; combined use with vasopressors may have additive cardiovascular effects.
Bleomycin: Historical concern that nitrous oxide may increase pulmonary toxicity risk in patients previously treated with bleomycin, though evidence is limited.
Clinical pearls
Key clinical considerations for safe and effective nitrous oxide use:
Practical administration
- Always use adequate scavenging systems to minimize occupational exposure in operating rooms and dental offices
- Administer 100% oxygen for 5-10 minutes after discontinuing nitrous oxide to prevent diffusion hypoxia
- Maximum concentration for labor analgesia is typically 50% (Entonox), self-administered intermittently
- For dental sedation, concentrations of 30-50% provide anxiolysis and mild analgesia while maintaining consciousness
Safety monitoring
- Always assess for contraindicated air-filled spaces before administration (chest X-ray for suspected pneumothorax, history of recent eye surgery)
- Consider checking vitamin B12 and homocysteine levels in patients requiring repeated exposures or those with risk factors for deficiency
- Monitor for signs of bowel distension during abdominal surgery if nitrous oxide is used
Exam-relevant associations
- Recreational abuse ("whippets" or "nangs"): Presents with subacute combined degeneration, often in young adults with normal dietary B12 intake; MRI shows T2 hyperintensity in dorsal columns ("inverted V sign")
- Nitrous oxide neuropathy is clinically indistinguishable from B12 deficiency but occurs with normal or elevated serum B12 (the B12 is present but oxidized and non-functional); elevated homocysteine and methylmalonic acid confirm functional deficiency
- Think of nitrous oxide exposure in any patient presenting with unexplained megaloblastic anemia plus neurologic symptoms
Clinical decision-making
- Avoid in procedures with high PONV risk unless benefits clearly outweigh risks; consider TIVA (total intravenous anesthesia) as alternative
- Particularly useful for short procedures requiring rapid recovery (e.g., MRI sedation in children)
- The environmental impact is increasingly considered in anesthetic choice; some institutions are reducing or eliminating routine use
Chronic exposure concerns
Healthcare workers with chronic unscavenged exposure may develop:
- Neurologic symptoms (numbness, ataxia)
- Bone marrow suppression
- Reduced fertility
Proper scavenging and room ventilation are essential for occupational safety.
Practice questions
1. A 28-year-old man presents to the emergency department with progressive weakness, numbness in his feet and hands, and difficulty walking that developed over 3 weeks. He reports using 50-100 whipped cream chargers daily for the past 6 months. Examination reveals decreased vibration and proprioception in the lower extremities, a positive Romberg sign, and hyperreflexia with extensor plantar responses. Complete blood count shows hemoglobin 9.2 g/dL with MCV 112 fL. Serum vitamin B12 level is 450 pg/mL (normal 200-900). Which of the following best explains this patient's presentation?
2. A 45-year-old woman is scheduled for laparoscopic cholecystectomy under general anesthesia with sevoflurane and nitrous oxide. During insufflation of the abdomen, the surgeon reports difficulty visualizing the surgical field due to significant bowel distension. Vital signs are stable. Which property of nitrous oxide best explains this finding?
3. A 32-year-old woman receives nitrous oxide for labor analgesia. After 8 hours of use, the anesthesiologist discontinues the nitrous oxide and removes the mask. Within 3 minutes, the patient becomes drowsy and her oxygen saturation drops from 98% to 88% on room air. Which of the following interventions would have most likely prevented this complication?
Frequently asked questions
How does nitrous oxide work?
Nitrous oxide works primarily by blocking NMDA receptors and activating opioid receptors in the central nervous system. This produces analgesia, mild anesthesia, and amnesia. It also activates descending pain inhibitory pathways and enhances GABAergic inhibition. The low blood-gas partition coefficient allows rapid onset within 2-5 minutes and quick recovery after discontinuation.
What are the side effects of nitrous oxide?
Common side effects include nausea, vomiting, dizziness, and euphoria. The most serious adverse effect is vitamin B12 inactivation with prolonged or chronic exposure, leading to megaloblastic anemia and subacute combined degeneration of the spinal cord with neurologic symptoms including numbness, ataxia, and weakness. Nitrous oxide also expands gas-filled spaces, which can worsen pneumothorax or cause bowel distension. Diffusion hypoxia can occur during emergence if supplemental oxygen is not provided.
Is nitrous oxide a controlled substance?
Nitrous oxide is not classified as a federally controlled substance under the DEA schedules in the United States for medical use. However, it is regulated for medical and dental use, and some states have laws restricting its sale for recreational purposes. Recreational abuse of nitrous oxide (inhaling from whipped cream dispensers or cartridges) is illegal in many jurisdictions and can cause serious neurologic damage.
Why is nitrous oxide contraindicated in pneumothorax?
Nitrous oxide is 35 times more soluble in blood than nitrogen, so it diffuses into air-filled spaces much faster than nitrogen diffuses out. This causes rapid expansion of the pneumothorax, potentially converting a small pneumothorax into a tension pneumothorax. The same principle applies to bowel gas, middle ear spaces, and pneumocephalus. This is one of the most important absolute contraindications to nitrous oxide use.
Nitrous oxide vs sevoflurane — what is the difference?
Nitrous oxide is a weak inhalational anesthetic (MAC 105%) used mainly for analgesia and as an adjunct, while sevoflurane is a potent volatile anesthetic (MAC 2%) capable of producing surgical anesthesia alone. Nitrous oxide has much faster onset and offset due to its lower blood-gas partition coefficient. Sevoflurane provides more reliable anesthesia but slower recovery. Nitrous oxide causes vitamin B12 inactivation and expands gas spaces; sevoflurane does not. Nitrous oxide reduces the MAC of sevoflurane, allowing use of lower concentrations of the more potent agent.
Conditions it is used for
Related drugs
Sources and further reading
DailyMed (FDA labels)StatPearls (NCBI Bookshelf)MedlinePlusWHO ATC/DDD index: N01AX13
Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.